Showing 3321-3330 of 4063 results for "".
- Lumibird Launches Tango Neo and UltraQ Reflex Neo Lasershttps://modernod.com/news/lumibird-launches-tango-neo-and-ultraq-reflex-neo-lasers/2481570/Following the launch of its flagship product, the Tango Reflex Neo, in December 2022, Lumibird Medical announced the launch of two additional variants within its premium Nd:YAG/SLT laser range—the UltraQ Reflex Neo and Tango Neo. A fully integrated Q-switched Nd:YAG lase
- Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at ASCRShttps://modernod.com/news/bausch-lomb-announces-the-presentation-of-new-scientific-data-on-products-and-pipeline-programs-at-ascrs/2481566/Bausch + Lomb announced the presentation of 21 podium presentations and four poster presentations related to the company’s products and pipeline programs during the A
- Iveric Bio Announces New Functional Vision Loss Reduction Data from Avacincaptad Pegol GATHER Trialshttps://modernod.com/news/iveric-bio-announces-new-functional-vision-loss-reduction-data-from-avacincaptad-pegol-gather-trials/2481557/Iveric bio announced new findings from exploratory analyses of data for avacincaptad pegol (ACP), which were presented at the 2023 annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) in New Orleans. A post-hoc analysis from the GATHER1 and GATHER2
- Apellis Presents Phase 3 Functional Analyses of Syfovre for Geographic Atrophyhttps://modernod.com/news/apellis-presents-phase-3-functional-analyses-of-syfovre-for-geographic-atrophy/2481553/Apellis Pharmaceuticals announced post hoc analyses from the 24-month, phase 3 OAKS and DERBY studies evaluating Syfovre (pegcetacoplan injection) for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The analyses were reported during oral presenta
- SightGlass Vision: Research Reinforces Myopia Control Efficacy and Safety of Diffusion Optics Technology Spectacle Lenseshttps://modernod.com/news/sightglass-vision-research-reinforces-myopia-control-efficacy-and-safety-of-diffusion-optics-technology-spectacle-lenses/2481552/SightGlass Vision announced positive outcomes of multiple studies designed to evaluate the performance of its Diffusion Optics Technology spectacle lenses, which are designed to slow the progression of myopia in children. All are being presented this week at the 2023 ARVO Annual Me
- Mina Sooch Replaced as CEO of Ocuphire Pharma; Claims No Cause was Givenhttps://modernod.com/news/mina-sooch-out-as-ceo-of-ocuphire-pharma-rick-rodgers-to-serve-as-interim-ceo/2481548/Ocuphire Pharma announced on Friday it has parted ways with Mina Sooch as CEO and President. Rick Rodgers, a board member since 2020, was appointed interim CEO and President. Ocuphire said it has retained an executive search firm to assist in identifying a permanent CEO.
- Bausch + Lomb to Present New Data on Products and Pipeline Programs at ARVOhttps://modernod.com/news/bausch-lomb-to-present-new-data-on-products-and-pipeline-programs-at-arvo/2481545/Bausch + Lomb announced the presentation of eight scientific poster presentations during the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, which will take place in New Orleans from April 23-27, 2023. The presentations include results from the 12-m
- Azura Ophthalmics to Present New Data on AZR-MD-001 in Meibomian Gland Dysfunction at ASCRS and ARVOhttps://modernod.com/news/azura-ophthalmics-to-present-new-data-on-azr-md-001-in-meibomian-gland-dysfunction-at-ascrs-and-arvo/2481544/Azura Ophthalmics announced multiple presentations featuring positive efficacy and safety data from a phase 2b study of the company’s lead drug candidate, AZR-MD-001, in Meibomian Gland Dysfunction (MGD). Data will be featured at the upcoming Annual Meetings for the Association for Research
- Iridex Announces US Launch of Next Generation PASCAL Laser with MicroPulsehttps://modernod.com/news/iridex-launches-next-gen-pascal-laser-with-micropulse-in-us/2481542/Iridex announced the full market launch of the next generation Iridex PASCAL platform. First offered in limited release in late 2022, the PASCAL is designed to provide an advanced technology package combining fast and precise pattern scanning capabilities, Endpoint Management Techn
- SightGlass Vision Highlights New Myopia Control Spectacle Lens Technologyhttps://modernod.com/news/sightglass-vision-highlights-new-myopia-control-spectacle-lens-technology/2481524/SightGlass Vision will share its myopia control spectacle lens technology at the International Congress of Ophthalmology and Optometry China (COOC), in partnership with Nikon Lenswear. The conference takes place in Shanghai from April 14-16, 2023. Spectacle lenses with SightGlass V